Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of histrelin acetate in China. Welcome to wholesale bulk high quality histrelin acetate for sale here from our factory. Good service and reasonable price are available.
Histrelin acetate, as an artificially synthesized gonadotropin-releasing hormone (GnRH) analog, has a wide range of applications in the medical field. It is a nine peptide with the chemical formula C66H86N18O12, molecular weight 1323.51, and CAS number 76712-82-8. It plays a key role in treating various diseases by simulating the natural action of GnRH and regulating the function of the hypothalamic pituitary gonadal axis. As an important gonadotropin-releasing hormone analog, it has a unique chemical structure and biological characteristics. By binding to GnRH receptors and regulating hormone levels, it has achieved significant results in treating diseases such as precocious puberty, prostate cancer, and endometriosis.
Our product






Histrelin COA
![]() |
||
| Certificate of Analysis | ||
| Compound name | Histrelin Acetate/Histrelin | |
| Grade | Pharmaceutical grade | |
| CAS No. | 220810-26-4/76712-82-8 | |
| Quantity | 46g | |
| Packaging standard | PE bag+Al foil bag | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
| Lot No. | 202501090069 | |
| MFG | Jan 9th 2025 | |
| EXP | Jan 8th 2028 | |
| Structure |
|
|
| Item | Enterprise standard | Analysis result |
| Appearance | White or almost white powder | Conformed |
| Water content | ≤5.0% | 0.54% |
| Loss on drying | ≤1.0% | 0.42% |
| Heavy Metals | Pb≤0.5ppm | N.D. |
| As≤0.5ppm | N.D. | |
| Hg≤0.5ppm | N.D. | |
| Cd≤0.5ppm | N.D. | |
| Purity (HPLC) | ≥99.0% | 99.98% |
| Single impurity | <0.8% | 0.52% |
| Total microbial count | ≤750cfu/g | 95 |
| E. Coli | ≤2MPN/g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (by GC) | ≤5000ppm | 500ppm |
| Storage | Store in a sealed, dark, and dry place below -20°C | |
|
|
||
|
|
||
chemical information
| Chemical Formula: | C66H86N18O12 |
| Exact Mass: | 1323 |
| Molecular Weight: | 1324 |
| m/z: | 1323 (100.0%), 1324 (71.4%), 1325 (25.1%), 1324 (6.6%), 1326 (5.8%), 1325 (4.7%), 1325 (2.5%), 1326 (1.8%), 1326 (1.7%) |
| Elemental Analysis: | C, 59.89; H, 6.55; N, 19.05; O, 14.51 |

Histrelin Acetate is an artificially synthesized gonadotropin-releasing hormone (GnRH) analogue, belonging to the GnRH receptor agonist class. It has a wide range of applications in the medical field, especially playing a key role in the treatment of diseases such as precocious puberty and prostate cancer.
Binding to GnRH receptor
(1) Structure and Function of GnRH Receptor
GnRH receptor is a G protein coupled receptor widely distributed on the surface of gonadotropin cells in the anterior pituitary gland. It consists of 7 transmembrane domains and exhibits typical structural features of G protein coupled receptors. GnRH receptors can specifically recognize and bind to natural GnRH, thereby initiating intracellular signaling pathways and regulating the secretion of gonadotropins. Gonadotropins include luteinizing hormone (LH) and follicle stimulating hormone (FSH), which play a crucial role in regulating gonadal function.
LH mainly acts on the interstitial cells of the testes, stimulating the synthesis and secretion of testosterone; In females, LH acts on the follicular membrane cells of the ovary, promoting the synthesis of estrogen and progesterone, as well as the maturation and ovulation of follicles. FSH mainly acts on the supporting cells of the testes, promoting sperm production; In females, FSH acts on granulosa cells in the ovaries, promoting follicle development and estrogen synthesis.
(2) Binding characteristics with receptors
As a GnRH analogue, its chemical structure is similar to natural GnRH, but with some unique modifications. It is a nine peptide composed of nine amino acid residues connected by peptide bonds, with D-histidine carrying a benzyl (Bzl) modification. This special structure endows histone with unique spatial conformation and biological properties, enabling it to specifically bind to GnRH receptors and have high affinity. Compared with natural GnRH, the binding of histamine to receptors is more stable and can activate receptors more persistently, thereby exerting stronger biological effects.
After entering the bloodstream, it spreads to the anterior pituitary gland and binds to the GnRH receptor on the surface of gonadotropin cells. This binding is reversible, and after binding to the receptor, the conformation of the receptor is altered, activating and initiating intracellular signaling pathways.
Intracellular signal transduction
(1) Activation of G protein
The GnRH receptor belongs to the G protein coupled receptor family, and when it binds to the receptor, it activates the G protein coupled to it. G protein is composed of three subunits: alpha, beta, and gamma. In the resting state, the three subunits of G protein are tightly bound, and the G alpha subunit binds to GDP. When the receptor is activated, G protein undergoes conformational changes, GDP is replaced by GTP, forming GTP-G α complex, and releasing G β - γ dimer. GTP-G α and G β - γ subunits regulate corresponding effectors in cells, thereby initiating intracellular signaling pathways.
(2) Activation of adenylate cyclase and generation of cAMP
The activated G α subunits (mainly G α s) act on adenylate cyclase (AC), activating it. AC catalyzes the generation of cyclic adenosine monophosphate (cAMP) using ATP as a substrate. CAMP is an important second messenger in cells, which can regulate the biological functions of downstream substrates by activating effectors such as cAMP dependent protein kinase A (PKA). In gonadotropin cells, an increase in cAMP production leads to the activation of PKA, which further phosphorylates a series of target proteins, thereby regulating cellular metabolism, gene expression, and other processes.
(3) Activation of phospholipase C and metabolism of inositol phospholipids
In addition to activating AC, binding to GnRH receptors can also activate phospholipase C (PLC) through Gq protein. PLC acts on phosphatidylinositol-4,5-diphosphate (PIP2) on the membrane, hydrolyzing histrelin acetate into inositol triphosphate (IP3) and diacylglycerol (DAG). IP3 can act on the IP3 receptor on the endoplasmic reticulum, releasing calcium ions from the endoplasmic reticulum into the cytoplasm, leading to an increase in intracellular calcium ion concentration.
Calcium ions are important signaling molecules in cells that can bind to calmodulin (CaM), activate calmodulin dependent kinases and other effectors, and regulate various biological functions of cells. DAG can activate protein kinase C (PKC), which can phosphorylate a series of target proteins and participate in cellular signal transduction, gene expression regulation, and other processes.
(4) Activation of other signaling pathways
In addition to the main signaling pathways mentioned above, binding to GnRH receptors may also activate other signaling pathways, such as the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. These signaling pathways interweave with each other and jointly regulate the biological functions of gonadotropin cells.
Regulation of hormone levels
After administration of tramadol, it initially causes an increase in circulating LH and FSH levels due to its binding to the GnRH receptor and activation of the receptor. This is because temerelin simulates the action of natural GnRH, stimulating the secretion of LH and FSH by gonadotropin cells in the anterior pituitary gland. The elevation of LH and FSH levels can lead to a transient increase in sex hormones, manifested as an increase in testosterone and dihydrotestosterone levels in males and an increase in estrogen and progesterone levels in females. This initial hormone elevation is a brief phase of the action of temerelin, typically lasting from several days to several weeks.
(2) Downregulation and Desensitization of Pituitary Receptors
However, continuous administration of tranexamic acid can lead to reversible downregulation of GnRH receptors in the pituitary gland and desensitization to pituitary hormones. This is due to long-term exposure to stimulation by temerelin, which reduces the expression and activity of GnRH receptors in pituitary cells through a series of mechanisms. On the one hand, cells accelerate the internalization and degradation of GnRH receptors, leading to a decrease in the number of receptors on the cell surface; On the other hand, the signal transduction pathways within cells undergo adaptive changes, leading to a weakened response to stimulation by histamine. The downregulation and desensitization process of pituitary receptors is a key mechanism for the long-term therapeutic effect of temerelin.
With the downregulation and desensitization of pituitary receptors, the secretion of LH and FSH gradually decreases. Due to the stimulation of female and male gonads to produce estrogen and androgen by LH and FSH, respectively, a decrease in LH and FSH levels can lead to a decrease in sex hormone levels. In males, a decrease in testosterone levels can inhibit the growth of prostate cancer cells, as the growth of prostate cancer cells depends on the stimulation of androgens. In females, a decrease in estrogen levels can alleviate symptoms such as endometriosis, as the occurrence and development of endometriosis are closely related to the action of estrogen.
(4) Long term therapeutic effect
By continuously administering histrelin acetate acid to maintain low levels of LH and FSH, the goal of long-term disease treatment can be achieved. When treating precocious puberty, reducing sex hormone levels can delay the process of sexual development, improve patients' height prognosis and psychosocial adaptability. In the treatment of prostate cancer, inhibiting the secretion of androgens can suppress the growth of tumor cells and prolong the survival of patients. When treating endometriosis, regulating hormone levels can alleviate pain, reduce the size and number of lesions, and improve the patient's quality of life.
FAQ
What is histrelin used for?
A drug used under the brand name Vantas as palliative therapy for advanced prostate cancer. Histrelin acetate initially causes the pituitary gland to make more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), temporarily increasing testosterone levels in men.
Is histrelin a GnRH agonist?
Histrelin is a GnRH agonist found in subcutaneous implants used for the treatment of pediatric patients with central precocious puberty and the palliative treatment of advanced prostate cancer.
What is the drug of choice for precocious puberty?
Treating central precocious puberty
This usually involves medicine called GnRH analogue therapy, which delays further development. It may be a monthly shot with medicine such as leuprolide acetate (Lupron Depot), or triptorelin (Trelstar, Triptodur Kit).
What is the generic for histrelin?
Supprelin LA. Supprelin LA (histrelin) helps prevent early puberty in children 2 years of age and older. The medication works well to delay puberty, but it's an implant that is placed under your skin during a minor surgical procedure.
Hot Tags: histrelin acetate, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, Bremelanotide Powder CAS 189691 06 3, DERMORPHIN, dermorphin peptide, Kisspeptin powder, Melanotan ii powder, Tesamorelin CAS 218949 48 5








